Ariceum Therapeutics
1 follower
‌
Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers.177Lu-satoreotide tetraxetan (Satoreotide), the company's primary target... Read more
Industries
+1
Headquarters
Employees
Links
Org chart
Manfred Ruediger
CEO of Ariceum Therapeutics GmbH
Manfred Ruediger
Collapse
Anika Jäkel
Senior Director
Dennis MEWIS
Head Of Laboratory - CMC & Radiopharmaceutical R&D
Germo Gericke
Chief Medical Officer
Manuel Sturzbecher-Hoehne
Head CMC and Radiopharmaceutical Development
Serge SAGODIRA
Chief Business Officer
Greg Mullen, PhD, FRSC
Chief Operating Officer
